Keywords: BDR Pharma, Sprycel, Compulsory license, India, Hospira, Precedex, Pediatric exclusivity, Perrigo, Generic Mucinex, USA

Briefs: BDR Pharma seeks Sprycel compulsory license; Hospira gains Precedex extension; Perrigo to start shipping generic Mucinex

Article | 18 March 2013

Indian generic drugmaker BDR Pharmaceuticals has applied to India's patent office for a compulsory licence to sell a generic version ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in